Published in Circ Res on July 19, 2016
A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers | NCT01281774
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). Circulation (2016) 1.43
Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis. Arterioscler Thromb Vasc Biol (2016) 0.76
Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit. BBA Clin (2017) 0.75
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med (2014) 8.61
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature (2006) 6.28
The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol (2010) 3.20
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem (2011) 2.33
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol (2015) 2.23
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol (2013) 2.12
Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol (2003) 1.93
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res (2005) 1.83
Cholesterol, inflammation and innate immunity. Nat Rev Immunol (2015) 1.72
High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem (2010) 1.69
Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol (2011) 1.66
Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim Biophys Acta (1993) 1.57
Antiatherogenic small, dense HDL--guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med (2006) 1.53
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol (2010) 1.39
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ Res (2015) 1.37
Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Commun (1978) 1.34
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem (2001) 1.30
Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions. J Lipid Res (1986) 1.27
ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med (2012) 1.15
Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux. Arterioscler Thromb Vasc Biol (2013) 1.09
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation. J Biol Chem (2003) 1.08
CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects. Arterioscler Thromb Vasc Biol (2014) 1.07
Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J Lipid Res (2010) 1.04
HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol (2009) 0.99
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial. Eur Heart J (2014) 0.98
Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase. Biochim Biophys Acta (1985) 0.97
The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. J Biol Chem (1995) 0.96
Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol (1995) 0.94
Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I. J Lipid Res (2005) 0.92
Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans. Arterioscler Thromb Vasc Biol (2015) 0.90
Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma. J Lipid Res (2002) 0.89
The anti inflammatory effects of high density lipoproteins. Curr Med Chem (2009) 0.88
A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. J Clin Pharmacol (2013) 0.86
Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochem J (2001) 0.86
Thermodynamics of the self-association of glucagon. Proc Natl Acad Sci U S A (1977) 0.85
Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling. Arterioscler Thromb Vasc Biol (2014) 0.80
Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J Lipid Res (1991) 0.80
HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res (2015) 0.79